Cencora Inc. (COR)
284.21
-0.12 (-0.04%)
At close: Apr 14, 2025, 3:13 PM
-0.04% (1D)
| Bid | 284.09 |
| Market Cap | 55.11B |
| Revenue (ttm) | 303.19B |
| Net Income (ttm) | 1.4B |
| EPS (ttm) | 7.05 |
| PE Ratio (ttm) | 40.31 |
| Forward PE | 15.38 |
| Analyst | Buy |
| Ask | 284.34 |
| Volume | 695,650 |
| Avg. Volume (20D) | 1,784,803 |
| Open | 283.17 |
| Previous Close | 284.33 |
| Day's Range | 281.52 - 285.01 |
| 52-Week Range | 214.77 - 296.65 |
| Beta | 0.54 |
About COR
Cencora, Inc. sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pha...
Industry Medical - Distribution
Sector Healthcare
IPO Date Apr 4, 1995
Employees 46,000
Stock Exchange NYSE
Ticker Symbol COR
Analyst Forecast
According to 9 analyst ratings, the average rating for COR stock is "Buy." The 12-month stock price forecast is $285, which is an increase of 0.28% from the latest price.
Stock ForecastsNext Earnings Release
Cencora Inc. is scheduled to release its earnings on May 7, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 days ago
+1.92%
Shares of REIT stocks are trading lower amid an ov...
Unlock content with
Pro Subscription
8 months ago
+2.96%
Cencora shares are trading higher after the company reported better-than-expected Q3 financial results and raised its FY24 adjusted EPS guidance above estimates.
